SCHEMBL14528489

SCHEMBL14528489

CC(C)Cn1c(-c2ccccc2Br)nc(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 4/20 0.56
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
FABP5 Q01469 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MAPK1 P28482 2/20 0.38
NPC1 O15118 1/20 0.37
MAPT P10636 1/20 0.37
CASP3 P42574 1/20 0.37
RAB9A P51151 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
FAAH O00519 2/20 0.36
TEK Q02763 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14528477 0.83 FABP4 (0.44) FABP4ALDH1A1FABP5KDM4EMAPK1
SCHEMBL14528727 0.79 FABP4 (0.65) FABP4ALDH1A1SMN1; SMN2FABP5KDM4E
SCHEMBL14528595 0.77 FABP4 (0.50) FABP4ALDH1A1SMN1; SMN2FABP5KDM4E
SCHEMBL14528482 0.73 FABP4 (1.00) FABP4ALDH1A1SMN1; SMN2FABP5KDM4E
SCHEMBL24427083 0.71 ALDH1A1 (0.47) FABP4ALDH1A1SMN1; SMN2KDM4ENPC1
SCHEMBL5197690 0.71 MAPK14 (0.44) FABP4FABP5NPSR1MEN1KMT2A
SCHEMBL13587979 0.69 MEN1 (0.47) FABP4ALDH1A1SMN1; SMN2FABP5KDM4E
SCHEMBL27207663 0.69 MEN1 (0.45) FABP4ALDH1A1FABP5KDM4EMEN1
SCHEMBL8235488 0.68 KDM4E (0.50) ALDH1A1SMN1; SMN2KDM4EMAPTTDP1
SCHEMBL26996417 0.68 CTSD (0.44) FABP4ALDH1A1SMN1; SMN2FABP5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1181014-B1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD BRISTOL MYERS SQUIBB CO (US) 2007-05-23 EP disclosed